GENEVA, Aug. 31 -- HUXLEY HEALTH, INC. filed a patent application (IB2026/051617) for “NEUROACTIVE DELIVERY BY NIOSOME NANOFORMULATION FOR IMPROVED BLOOD-BRAIN-BARRIER PENETRATION”. With publication no. WO/2026/176368, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/7048
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....